Tuesday, November 2, 2021

Pfizer’s pneumococcal disease vaccine scores FDA priority review




The US Food and Drug Administration (FDA) has granted Pfizer’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate a priority review for the prevention of pneumococcal disease.

Pfizer is eyeing approval for the vaccine candidate as a preventative shot against invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older.

The FDA has already handed Pfizer a fast track designation for 20vPnC to potentially be used in adults aged 18 years and older for the prevention of invasive pneumococcal disease, as well as a breakthrough therapy designation.

The 20vPnC vaccine candidate comprises capsular polysaccharide conjugates for the 13 serotypes already included in Pfizer’s Prevnar 13, as well as capsular polysaccharide conjugates for seven additional serotypes that cause invasive pneumococcal disease (IPD).

The seven additional serotypes have been associated with high case-fatality rates, antibiotic resistance and/or meningitis, Pfizer added in a statement.

Pneumococcal pneumonia causes approximately 500,000 deaths and 30 million episodes in adults aged 70 years and older each year globally.

“The FDA’s acceptance of our application for 20vPnC is yet another significant milestone in Pfizer’s continuing efforts to help protect adults against pneumococcal disease,” said Kathrin Jansen, senior vice president and head of vaccine research and development, Pfizer.

“If approved, 20vPnC will cover more serotypes responsible for the majority of pneumococcal disease than any other pneumococcal conjugate vaccine currently licensed or currently in late-stage clinical development. Importantly, 20vPnC has shown to induce immune memory, which provides protection and efficacy against non-bacteremic pneumonia, particularly in older adults,” she added.

Following the acceptance of the priority review for Pfizer’s 20vPnC, the FDA has set a goal date for a decision on the vaccine candidate in June 2021.



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...